“Global Pneumatic Tourniquet Market to reach a market value of 654.9 Million by 2031 growing at a CAGR of 6.9%”
The Global Pneumatic Tourniquet Market size is expected to reach $654.9 million by 2031, rising at a market growth of 6.9% CAGR during the forecast period.
As healthcare systems in the Asia-Pacific region develop, there is a greater emphasis on improving patient safety and outcomes. These tourniquets are valued for their precision and ability to control blood flow, aligning with this focus on quality care. Consequently, the Asia Pacific region would acquire nearly 28% of the total market share by 2031.
As healthcare expenditures increase, hospitals and medical facilities can allocate additional resources to the acquisition of sophisticated medical technologies, such as these tourniquets. Higher healthcare expenditure often leads to expanding healthcare services, including the growth of surgical departments and specialized clinics. In conclusion, increased healthcare expenditure worldwide is driving the market's growth.
Additionally, Aging populations, chronic disease management, and patient preference for care at home drive the growing trend towards home healthcare. In addition, home healthcare provides patients with the comfort of being in a familiar environment. These tourniquets at home enhance patient convenience, allowing continuous care without frequent hospital visits. Therefore, expansion into home healthcare is propelling the growth of the market.
However, Advanced tourniquet systems often feature sophisticated technology and enhanced functionalities and come with higher price tags. Also, advanced tourniquet systems often require specialized maintenance and training, which can further increase the total cost of ownership. Thus, the high costs associated with advanced tourniquet systems hinder the market's growth.
Moreover, Regulatory processes for medical devices, including these tourniquets, faced delays due to the pandemic. These delays affected the introduction and approval of new products in the market. Manufacturers faced operational challenges due to lockdowns and restrictions, impacting their ability to maintain normal production schedules and meet market demand for these tourniquets. Thus, the COVID-19 pandemic had a negative impact on the market.
On the basis of application, the market is segmented into orthopedic, intravenous regional anesthesia, and others. In 2023, the intravenous regional anesthesia segment attained 32% revenue share in the market. These tourniquets offer precise control over pressure, which is crucial for maintaining the desired level of blood flow restriction during IVRA.
Based on type, the market is divided into single bladder tourniquet and double bladder tourniquet. The double bladder tourniquet segment witnessed 36% revenue share in the market in 2023. Double bladder tourniquets offer superior haemostasis using two inflatable bladders within a single cuff. This design allows for more precise and uniform pressure distribution around the limb.
Free Valuable Insights: Global Pneumatic Tourniquet Market size to reach USD 654.9 Million by 2031
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region witnessed a 37% revenue share in the market in 2023. North America, especially the United States and Canada, has a highly developed healthcare infrastructure that strongly emphasizes advanced medical technologies and practices.
| Report Attribute | Details |
|---|---|
| Market size value in 2023 | USD 388.1 Million |
| Market size forecast in 2031 | USD 654.9 Million |
| Base Year | 2023 |
| Historical Period | 2020 to 2022 |
| Forecast Period | 2024 to 2031 |
| Revenue Growth Rate | CAGR of 6.9% from 2024 to 2031 |
| Number of Pages | 164 |
| Number of Tables | 250 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives |
| Segments covered | Type, Application, Region |
| Country scope |
|
| Companies Included | Ane-c Aid Ltd., Stryker Corporation, VBM Medizintechnik GmbH, Zimmer Biomet Holdings, Inc., SPENGLER HOLTEX Group, Shanghai Huifeng Medical Instrument Co., Ltd., Jiangsu Qianjing Medical Equipment Co.,Ltd (Jiangsu Qianjing Technology Development Group), The Seaberg Company Inc. (SAM Medical), Hammarplast Medical AB and OHK Medical Devices, Inc. |
By Type
By Application
By Geography
This Market size is expected to reach $654.9 million by 2031.
Increased healthcare expenditure worldwide are driving the Market in coming years, however, Risk of complications and adverse effects restraints the growth of the Market.
Ane-c Aid Ltd., Stryker Corporation, VBM Medizintechnik GmbH, Zimmer Biomet Holdings, Inc., SPENGLER HOLTEX Group, Shanghai Huifeng Medical Instrument Co., Ltd., Jiangsu Qianjing Medical Equipment Co.,Ltd (Jiangsu Qianjing Technology Development Group), The Seaberg Company Inc. (SAM Medical), Hammarplast Medical AB and OHK Medical Devices, Inc.
The expected CAGR of this Market is 6.9% from 2024 to 2031.
The Single Bladder Tourniquet segment led the Market by Type in 2023; thereby, achieving a market value of $408 Million by 2031.
The North America region dominated the Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $230 Million by 2031.
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 